2017 annual financial data
BioCryst Pharmaceuticals 2017 Operating margin
BioCryst Pharmaceuticals 2017 operating margin with verified reported values.
Direct answer
Operating margin was -227.95%.
Operating income was -57,411,000 USD and net income was -65,782,000 USD.
Operating cash flow was -41,143,000 USD.
Get free BioCryst Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 25,186,000 USD
- Operating income
- -57,411,000 USD
- Net income
- -65,782,000 USD
- Operating cash flow
- -41,143,000 USD